Loading organizations...
§ Private Profile · Portland, OR, USA
Oath Surgical is a technology company.
Oath Surgical develops and operates outpatient surgical centers that provide high-quality, lower-cost surgical care in convenient settings. The company integrates proprietary technology with human skill to streamline the entire surgical journey, from initial referral through to recovery, ensuring personalized and efficient care. This approach focuses on delivering superior outcomes and patient satisfaction by optimizing outpatient procedures.
The company was founded by Oliver Keown, MD, who serves as CEO. With a background as a trained surgeon and significant experience in healthcare investment, Dr. Keown established Oath Surgical in response to the observed shift of complex care towards outpatient settings. His insight centered on blending digital infrastructure with clinical excellence to build a more efficient and patient-centric surgical ecosystem.
Oath Surgical serves patients across a range of specialties, including movement health, gut health, and ENT. It also provides an environment for quality-oriented surgeons to practice efficiently and partners with payors seeking value-based care arrangements. The company's vision is to redefine outpatient surgical care by making it more accessible and effective, prioritizing patient and medical staff satisfaction while enhancing surgical outcomes.
Oath Surgical has raised $34.0M across 2 funding rounds.
Oath Surgical has raised $34.0M in total across 2 funding rounds.
Oath Surgical has raised $34.0M across 2 funding rounds. Most recently, it raised $24.0M Series A in October 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Oct 1, 2025 | $24M Series A | FPV Fund | Kinnevik, Playground Global, Black Opal Ventures, McKesson Ventures, Oxford Science Enterprises, Rogue VC, TAU Ventures | Announced |
| May 14, 2025 | $10M Seed | — | — | Announced |
Oath Surgical has raised $34.0M in total across 2 funding rounds.
Oath Surgical's investors include FPV Fund, Kinnevik, Playground Global, Black Opal Ventures, McKesson Ventures, Oxford Science Enterprises, Rogue VC, Tau Ventures.
Oath Surgical is a health tech startup building a vertically integrated platform for outpatient surgery, centered on OathOS, a proprietary AI-powered operating system that manages the full surgical journey from referral to recovery.[1][2][3] It operates tech-first ambulatory surgery centers (ASCs) co-owned by vetted surgeons, targeting complex procedures traditionally done in hospitals, to deliver value-based care with better outcomes, lower costs, and reduced administrative burden for patients, surgeons, and payors.[1][2][4] Launched in Portland, Oregon, with national expansion plans, the company serves patients needing higher-acuity outpatient surgeries, surgeons seeking ownership and efficiency tools, and payors aligned on cost savings; it has raised $35M total, including a $24M oversubscribed Series A in October 2025, signaling strong growth momentum amid rising demand for outpatient care.[3][6]
Oath Surgical emerged from stealth in May 2025, founded by Dr. Oliver Keown, a trained physician, former head of Intuitive Ventures (the venture arm of surgical robotics firm Intuitive Surgical), and veteran of medtech investing.[1][2][3] Keown's idea stemmed from a decade observing surgical inefficiencies—fragmented systems, hospital dependency for complex procedures, and misaligned incentives—despite advances in minimally invasive tech and robotics enabling safer outpatient care.[3][4] Pivotal early traction included launching its first ASC in Portland with OathOS already in use for AI scribes, automated charting, and pre-op workflows, plus securing initial funding from Oxford Science Enterprises and others before the Series A led by FPV Ventures.[1][2][6]
Oath Surgical stands out through vertical integration of AI software and owned ASCs, creating a full-stack system rather than point solutions:
Oath Surgical rides the shift toward outpatient and value-based surgical care, fueled by robotics/minimally invasive tech enabling complex procedures outside hospitals, amid market forces like rising healthcare costs, payor pressure for efficiency, and AI's maturation for backend automation.[1][3][4] Timing is ideal post-2025 funding boom, with $35M enabling oncology expansion and national density in regional networks, countering legacy systems' bloat.[3][6] It influences the ecosystem by proving scalable AI-physical integration, inspiring surgeon-centric models, and unlocking ROI through episode-of-care ownership, potentially accelerating ASC growth from 5-10% of U.S. surgeries to higher shares.[2][4]
Oath Surgical is poised to scale its national network of AI-powered ASCs, expanding into oncology and more specialties with fresh Series A capital, while refining OathOS for deeper payor integrations and performance analytics.[6][8] Trends like AI ubiquity in healthcare, ASC proliferation (projected to handle 50%+ of procedures), and value-based shifts will propel it, though execution risks include regulatory hurdles and surgeon recruitment. Its influence may evolve from pioneer to platform leader, redefining surgery as efficient, outpatient-first—echoing its launch thesis that tech can untether complex care from hospitals for good.[1][3]